Drug intelligence / Profile preview

clotrimazole + metronidazole

Development stage
Unknown
Lead developer
Sanofi
Modality
Small Molecules
Administration
Vaginal
01

Overview

Clotrimazole + metronidazole is a fixed-dose combination of two small molecule drugs used primarily for the treatment of vaginal infections, especially mixed infections involving both fungi and anaerobic bacteria. Clotrimazole is an imidazole antifungal agent that inhibits the synthesis of ergosterol, a key component of fungal cell membranes, thereby stopping fungal growth. Metronidazole is a nitroimidazole antibiotic and antiprotozoal agent that works by entering microbial cells and generating free radicals which damage DNA, leading to cell death. This combination targets both fungal pathogens (such as Candida species) and anaerobic bacteria commonly implicated in vaginitis[5]. It is typically administered intravaginally as tablets or gel.

Brand names
Candid-V GelClingen Vaginal SuppositoryGinlac Vaginal Tablet
Other names
metronidazole + clotrimazole
02

Targets

CYP51A1 (Sterol 14α-demethylase)Neuraminidase

Beyond the preview

Go deeper on clotrimazole + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clotrimazole + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call